Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.41 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.41 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.41 |
| ▸ | GBA1 | P04062 | 3/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12611330 | 1.00 | GPR84 (0.41) | GPR84SPHK1FFAR1GBA1 | |
| SCHEMBL3490657 | 0.74 | GPR84 (0.43) | GPR84SPHK1FFAR1GBA1 | |
| SCHEMBL9173346 | 0.74 | GPR84 (0.43) | GPR84SPHK1FFAR1GBA1 | |
| SCHEMBL17099449 | 0.74 | GPR84 (0.43) | GPR84SPHK1FFAR1GBA1 | |
| SCHEMBL31562884 | 0.74 | GPR84 (0.43) | GPR84SPHK1FFAR1GBA1 | |
| SCHEMBL729642 | 0.73 | GBA1 (0.33) | GBA1 | |
| SCHEMBL9173056 | 0.71 | GPR84 (0.40) | GPR84SPHK1FFAR1 | |
| SCHEMBL4359776 | 0.71 | GPR84 (0.40) | GPR84SPHK1FFAR1 | |
| SCHEMBL2356094 | 0.71 | ALDH1A1 (0.43) | — | |
| SCHEMBL52122 | 0.71 | ALDH1A1 (0.43) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8450533-B2 | Cyclopropanation process | GIVAUDAN SA (CH) | 2013-05-28 | — | — | US | disclosed |
| US-20110124924-A1 | Cyclopropanation Process | GIVAUDAN SA (CH) | 2011-05-26 | — | — | US | disclosed |
| EP-2190803-A1 | CYCLOPROPANATION PROCESS | Givaudan SA (CH) | 2010-06-02 | — | — | EP | disclosed |
| WO-2009023980-A1 | CYCLOPROPANATION PROCESS | GIVAUDAN SA (CH) | 2009-02-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110124924-A1 | Cyclopropanation Process | CBR3, CYP4F3, DBF4 | GPR84 2374/4885SPHK1 2845/4885FFAR1 1271/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.